X-ray structure investigation of (20S)-20-O-β-D-Glucopyranosyl-protopanaxadiol and antitumor effect on Lewis lung carcinoma in vivo

Chemistry and Biodiversity

Volumn 6, Issue 3, 2009, Pages 380-388

  Zhou, Wei ^a   Feng, Meiqing ^a   Li, Xinwei ^a   Yan, Qin ^a   Zhou, Chaoqun ^a   Li, Jiyang ^a   Zhou, Pei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

20 O BETA DEXTRO GLUCOPYRANOSYLPROTOPANAXADIOL; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; GINSENG SAPONIN; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; DRUG STRUCTURE; IMMUNOREGULATION; IN VIVO STUDY; LEUKOCYTE; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; CYCLOHEXIMIDE; GINSENOSIDES; MALE; MICE; MICE, INBRED C57BL;

PANAX GINSENG;

EID: 64549099918     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200700444     Document Type: Article

References (20)

1. H.-U. Lee, E.-A. Bae, M. J. Han, D.-H. Kim, Biol. Pharm. Bull. 2005, 28, 1992.
2. W. Park, W. Lim, J. Cho, H. Inoue, M.-R. Rhyu, Y. J. Lee, Planta Med. 2006, 72, 272.
3. H.-S. Zhang, S.-Q. Wang, J. Cell. Biochem. 2006, 98, 1471.
4. S. Yahara, K. Kaji, O. Tanaka, Chem. Pharm. Bull. 1979, 27, 88.
5. R. Kasai, H. Besso, O. Tanaka, Y. I. Saruwatari, T. Fuwa, Chem. Pharm. Bull. 1983, 31, 2120.
6. M. Karikura, T. Miyase, H. Tanizawa, Y. Takino, T. Taniyama, T. Hayashi, Chem. Pharm. Bull. 1990, 38, 2859.
7. T. Akao, H. Kida, M. Kanaoka, M. Hattori, K. Kobashi, J. Pharm. Pharmacol. 1998, 50, 1155.
8. E.-A. Bae, M.-K. Choo, E.-K. Park, S.-Y. Park, H.-Y. Shin, D. H.-Kim, Biol. Pharm. Bull. 2002, 25, 743.
9. Y. W. Shin, D. H. Kim, J. Pharmacol. Sci. 2005, 99, 83.
10. H.-U. Lee, E.-A. Bae, M. J. Han, N.-J. Kim, D.-H. Kim, Liver Int. 2005, 25, 1069.
11. E.-K. Park, Y.-W. Shin, H.-U. Lee, S.-S. Kim, Y.-C. Lee, B.-Y. Lee, D.-H. Kim, Biol. Pharm. Bull. 2005, 28, 652.
12. H. Hasegawa, S. Matsumiya, M. Uchiyama, T. Kurokawa, Y. Inouye, R. Kasai, S. Ishibashi, K. Yamasaki, Planta Med. 1994, 60, 240.
13. S.-H. Oh, B.-H. Lee, Toxicol. Appl. Pharm. 2004, 194, 221.
14. Y.-J. Lee, J.W. Shin, K.-S. Chun, K.-K. Park, W.-Y. Chung, Y.-J. Bang, J.-H. Sung, Y.-J. Surh, Carcinogenesis 2005, 26, 359.
15. C. Wakabayashi, K. Murakami, H. Hasegawa, J. Murata, I. Saiki, Biochem. Biophys. Res. Commun. 1998, 246, 725.
16. R. Dey, V. Langer, P. Roychowdhury, S. Roychowdhury, M. G. B. Drew, Acta Crystallogr., Sect. C 2005, 61, o201.
17. SMART v. 5.049, Bruker AXS Inc., Madison, WI, 1999.
18. SAINT v. 5.00, Bruker AXS Inc., Madison, WI, 1999.
19. G. M. Sheldrick, SHELXS-97, Program for the Solution of Crystal Structure; University of Göttingen, Göttingen, 1997.
20. G. M. Sheldrick, SHELXL-97, Program for the Refinement of Crystal Structure, University of Göttingen, Göttingen, 1997.